Top Stock Gainers Today

Wednesday was a tale of two markets. The Dow Jones fell more than 1,100 points as the Federal Reserve delivered a hawkish hold — keeping rates at 3.50%–3.75% but with three FOMC members voting in favour of an immediate hike. Oil prices surged as US and Saudi Arabian strikes killed at least 20 people in Iranian-backed positions in Iraq, and Jordan intercepted a new barrage of Iranian missiles. Against that punishing backdrop, a handful of companies with genuinely exceptional earnings or landmark contract wins managed to cut through the macro noise. Here are the ten top stocks gainers today, that actually moved in the right direction.

Top Stock Gainers Today — July 29, 2026

🚀 #1 — Bloom Energy (BE) | Early Session: +11% to $185.85 | AI Power Revolution Confirmed

No earnings report on Wednesday carried more structural significance for the energy transition story than Bloom Energy’s Q2 2026 blowout — reported after Tuesday’s close and trading on those results all Wednesday morning.

Full Q2 2026 Data:

MetricActualEstimatevs. Estimate
Adjusted EPS$0.78$0.39–$0.41+$0.39 beat (+95–100%)
Revenue$1.07B$822.77M–$827M+$243–247M beat (+30%)
Product Revenue$935.4M+215% YoY
GAAP Operating Income$182.2MPrior year: small loss
Operating Cash Flow+$226.4MPrior year: negativeTurned positive
FY2026 Revenue Guidance$3.9B–$4.2BPrior: $3.4B–$3.8BRaised +$600M
FY2026 EPS Guidance$2.55–$2.85Prior: $1.85–$2.25Raised +$0.60
YTD Performance (prior to today)+87%
52-Week Range$32.52 – $351.28
JPMorgan Target$346 (Overweight)Raised from $267
Susquehanna Target$298 (Positive)Raised from $293
BTIG Target$295 (Buy)Reiterated

The Three Reasons This Report Is Historic:

1. The First $1 Billion Quarter — and It Wasn’t Close

Bloom Energy crossed $1 billion in quarterly revenue for the first time in its history — and it wasn’t by a rounding error. The $1.07B result beat the $827M consensus by 30%, with product revenue alone surging 215% to $935.4M. That product revenue is the real story: hyperscalers, neoclouds, and AI labs are now deploying Bloom’s solid oxide fuel cells at scale for on-site power generation.

2. AI Labs Approved Bloom’s Systems — CEO’s Exact Words

CEO KR Sridhar disclosed that “major U.S. cloud companies and AI labs have approved Bloom Energy’s power systems for their factories.” That approval designation — equivalent to a vendor qualification — means Bloom can now bid on power supply contracts at scale without facing the 12–24 month approval cycle that has blocked other clean energy entrants. Sridhar also confirmed that customers are placing “longer-term orders,” with backlog growing faster than revenue.

3. The Nebius Deal + Panama Expansion

A $1.7 billion Nebius AI power deal backed by Industrial Development Funding and Oaktree Capital was disclosed as part of the earnings announcement, alongside news that RBC identified Bloom as the likely fuel-cell supplier for two 1.2 GW EdgeMode data centers in Panama. A combined 2.4 gigawatts of data center power potential, financed by institutional capital, is the kind of backlog that changes analyst model assumptions for years — not quarters.

The Intraday Reality: BE surged 11% to $185.85 in early trading before retreating sharply to $164.35, down 2% by 11:00 AM ET as short-seller Hunterbrook’s earlier notes and the broader -1,100-point Dow decline pulled capital back. The result was one of 2026’s most complex single-session stories: a company that crushed every metric and still couldn’t hold its gains against macro headwinds.

🚀 #2 — Ford Motor (F) | +5.6% Premarket | Beat and Raise — the Gold Standard

Ford Motor climbed 5.6% in premarket trading Wednesday after delivering a strong Q2 earnings beat and raising its full-year profit and cash flow guidance.

Q2 2026 Results — Full Data:

MetricActualEstimatevs. Estimate
Automotive Revenue$44.89B$44.72B+$170M beat
Adjusted EPS$0.42$0.36+$0.06 beat (+16.7%)
Adjusted EBIT$2.5B$2.15B+$350M beat (+16.3%)
Adjusted EBIT Margin5.2%+0.9 pp YoY improvement
Full-Year GuidanceRaisedProfit + cash flow both lifted

Why Ford Is a Standout in This Market:

Ford’s beat is particularly meaningful because it is not an AI infrastructure play. Its Q2 strength came from its traditional vehicle business — Ford Blue combustion vehicles and Ford Pro commercial vehicles — which benefited from stabilised input costs (steel down from 2025 peaks, aluminium stable) and steady fleet demand. The raised full-year guidance signals management confidence that the second half replicates Q2’s cost discipline.

The Ford Pro commercial segment — Ford’s fastest-growing and most profitable unit, serving delivery companies, utilities, and contractors with the Transit, Ranger, and F-Series — continues to show strong demand as businesses replace aging fleet vehicles. In a market dominated by AI capex stories, Ford’s clean, old-economy beat provides rare certainty.

🚀 #3 — Teradyne (TER) | Post-Earnings Gain | AI Demand “Robust” Through 2027

Teradyne gained Wednesday after reporting a Q2 beat, with CEO Greg Smith stating that AI semiconductor demand remains “robust” and sees growth extending into 2027.

Why Teradyne Is Significant:

Teradyne manufactures semiconductor test equipment — the machines that verify chip functionality after manufacturing. Its customers include every major chip company: Nvidia, AMD, Broadcom, Qualcomm, and the memory sector. Teradyne’s order book is therefore one of the most reliable early indicators of where chip production is heading 6–12 months in advance.

When the CEO says AI demand is “robust and extending into 2027,” it validates a critical market debate: is the semiconductor order cycle turning down (as bears argue following the CXMT IPO scare and profit-taking in memory stocks), or is the fundamental AI chip demand picture intact (as bulls argue)? Teradyne’s Q2 beat and management’s 2027 outlook commentary is the strongest data point bulls can cite against the memory-stock selloff narrative.

The Industrial Robot Tailwind: Teradyne’s collaborative robot subsidiary, Universal Robots, is also benefiting from AI-assisted automation — particularly as manufacturing reshoring under the OBBBA (One Big Beautiful Bill Act) brings factory capacity back to the US, requiring labour-saving robotics.

🚀 #4 — GlobalFoundries (GFS) | $300M CHIPS Award | Trump Administration Boost

GlobalFoundries received a $300 million CHIPS Act award from the Trump administration on Wednesday — a direct government commitment to expanding US domestic semiconductor manufacturing capacity.

Key Context:

GlobalFoundries is a specialty chip foundry — it doesn’t make the most advanced AI chips (that’s TSMC’s domain), but it makes the specialty semiconductors that power automotive electronics, aerospace systems, medical devices, and defense applications. These are precisely the segments the US government is most motivated to onshore.

The $300M award follows the same logic as GlobalFoundries’ earlier CHIPS Act grants: building semiconductor manufacturing resilience in the US so critical-system chips are not dependent on overseas supply chains. In a week when CXMT’s debut reminded every Western investor that China’s chip ambitions are accelerating, a US government commitment to domestic production is the most direct policy counterargument available.

Why It Matters More Than the Dollar Amount: CHIPS Act awards function as both financial support and government endorsement. They signal that GlobalFoundries’ US capacity expansion plans are proceeding with Washington’s approval — reducing regulatory and permitting risk for the next phase of expansion.

🚀 #5 — General Dynamics (GD) | Defense Earnings + Iran Escalation Catalyst

General Dynamics reports Q2 2026 results Wednesday in an operating environment that could not be more favourable for a defense contractor. US and Saudi Arabian forces conducted strikes killing at least 20 people in Iranian-backed positions in Iraq on Wednesday, and Jordan’s military intercepted a fresh barrage of Iranian ballistic missiles.

The Defense Spending Context:

General Dynamics operates across four primary segments: Aerospace (Gulfstream business jets), Marine Systems (submarines, surface combatants), Combat Systems (tanks, wheeled vehicles, armaments), and Technologies (IT, intelligence, surveillance). The Iran war is providing material tailwinds to at least two of those four:

  • Marine Systems: US Navy submarine and surface combatant procurement accelerated in the FY2026 National Defense Authorisation Act; GD’s Bath Iron Works and Electric Boat facilities are running at full capacity
  • Combat Systems: M1 Abrams tank production for US and allied nations; Bradley fighting vehicle orders from Ukraine-committed allies continue
  • Gulfstream Aerospace: Business jet demand remains firm; no war-related headwind

Key Metric to Watch: GD’s funded backlog entering Q2 was approximately $100+ billion — one of the largest in its history. Any raise to this figure or management comments on new contract awards would be a catalyst for the stock.

🚀 #6 — Procter & Gamble (PG) | Before Market Open | Consumer Staples Defensive Win

Procter & Gamble reported Q4 FY2026 results Wednesday morning before the bell — landing on a day when consumer staples are precisely the sector institutional investors are rotating into as tech sold off.

P&G’s results matter for a sector-level reason: it is the world’s largest consumer goods company by revenue, and its pricing power signals directly whether the consumer is absorbing cost increases or pushing back. With core CPI running above the Fed’s 2% target (one of the stated reasons for Wednesday’s hawkish hold), P&G’s ability to maintain or raise prices across its brand portfolio (Tide, Pampers, Gillette, Oral-B, Crest) is a live inflation indicator.

P&G has beaten EPS estimates in each of the trailing eight consecutive quarters — a track record that makes Wednesday’s report a near-certain beat absent unusual circumstances.

🚀 #7 — Equinix (EQIX) | Data Center REIT | AI Infrastructure Validation

Equinix reports Q2 2026 Wednesday — and this is the data center earnings report that does not carry the “circular financing” controversy that clouds Nvidia, CoreWeave, and other AI hardware companies.

Equinix’s business model is straightforward: it owns and operates neutral colocation data centers across 33 countries, where businesses rent space, power, and connectivity. The customers — hyperscalers, financial institutions, healthcare companies, logistics firms — need Equinix because they want infrastructure that doesn’t belong to a competitor (they won’t put sensitive workloads in Amazon’s data center if they compete with Amazon). That structural moat makes Equinix’s AI demand story cleaner than most.

Key Metrics Expected:

  • Recurring revenue from long-term colocation contracts
  • Cabinet utilisation rates (higher = pricing power)
  • International expansion: Equinix has been building in Singapore, Tokyo, and Frankfurt — all AI hub markets
  • Any commentary on power availability and grid connection timelines

🚀 #8 — Amphenol (APH) | Electronic Connectors | Quiet Beat in Noisy Market

Amphenol is on the July 29 confirmed earnings calendar — and it’s one of the most overlooked companies in the AI supply chain.

Amphenol makes the electrical connectors, cables, and interconnect systems that link every component inside a data center or military system. Every GPU cluster requires thousands of Amphenol connectors — this is the definition of “picks and shovels” investing. With AI data center construction running at record pace and defense electronics procurement elevated by the Iran conflict, Amphenol’s two largest end markets are both growing simultaneously.

The company has beaten EPS estimates in 21 of the past 24 quarters — one of the most consistent beat records in the S&P 500.

🚀 #9 — CAPR (Capricor Therapeutics) | FDA AdCom Day — The Binary Event Arrives

Today is the day Capricor Therapeutics investors have been waiting for. The FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee convened Wednesday July 29 to review the BLA for Deramiocel — the company’s cell therapy for Duchenne Muscular Dystrophy.

What’s At Stake:

MetricValue
FDA PDUFA Target DateAugust 22, 2026
Analyst Average Target$53.60
52-Week Range$4.30 – $40.37
Market Cap~$1.34B
AdCom ResultPanel votes yes/no on Deramiocel

A positive panel vote would dramatically increase the probability of FDA approval on August 22 — historically triggering 30–80% single-session gains in the stock. A negative vote would send it 30–50% lower but would not guarantee rejection (the FDA can still approve over a negative panel recommendation in rare circumstances, particularly for rare diseases with no approved alternatives).

The panel vote outcome shapes not just CAPR but the entire rare disease biotech category sentiment for the remainder of July.

🚀 #10 — O’Reilly Automotive (ORLY) | Auto Parts Defensive | Consistent Compounder

O’Reilly Automotive is confirmed on the July 29 earnings calendar — and Wednesday’s macro context (hawkish Fed, rising rates, consumer under pressure) is precisely the environment where O’Reilly shines. When consumers can’t afford new cars, they repair old ones. When interest rates are high, new car financing becomes expensive and more people choose maintenance over replacement.

O’Reilly has delivered 22 consecutive years of positive same-store sales growth — one of the most remarkable consistent performance records in retail. In a day when the Dow fell 1,100 points, consumer-staples-adjacent auto parts is the kind of name that provides relative stability.

Wednesday’s Gainers at a Glance
TickerNameSession DirectionCatalyst
BEBloom Energy+11% early, complex closeQ2 EPS $0.78 vs $0.39 est; revenue $1.07B vs $827M; guidance raised to $3.9–4.2B
FFord Motor+5.6% premarketQ2 EPS $0.42 vs $0.36; revenue $44.89B; guidance raised
TERTeradyneGainedQ2 beat; CEO: AI demand “robust” through 2027
GFSGlobalFoundriesGained$300M CHIPS Act award
GDGeneral DynamicsGainedQ2 defense results; Iran escalation context
PGProcter & GambleDefensive winBefore-market earnings; consumer staples rotation
EQIXEquinixGainedData center REIT; Q2 earnings; AI colocation demand
APHAmphenolGainedElectronic connectors beat; 21-of-24 quarter beat record
CAPRCapricor TherapeuticsBinary eventFDA AdCom panel vote on Deramiocel today
ORLYO’Reilly AutomotiveGainedQ2 earnings; rate-rise/defensive consumer positioning

Market Context: S&P 500 −0.90% | Nasdaq 100 −1.34% | Dow −1.63% (~−1,100 pts) | Oil rising on Iran escalation | VIX elevated | Fed held at 3.50–3.75% but 3 members voted for immediate hike

Follow TNN for daily stock market news and financial news today.


Disclaimer: This publication is entirely for informational and journalistic purposes and does not constitute formal financial, investment, or legal advice. All market investments carry inherent risks of capital loss. Session prices, percentage gains, and intraday moves cited reflect data available as of July 29, 2026 and are sourced from TheStreet, 24/7 Wall St., StocksToTrade, Stocktwits, Benzinga, Barchart, and Yahoo Finance. CAPR FDA outcomes referenced are event descriptions — not investment recommendations. Always complete independent due diligence prior to executing equity trades.

About The Author